Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 1
2009 2
2010 2
2011 1
2012 4
2013 2
2014 2
2015 2
2016 4
2017 5
2018 7
2019 5
2020 5
2021 8
2022 7
2023 12
2024 8
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.
Fujii H, Iwaki M, Hayashi H, Toyoda H, Oeda S, Hyogo H, Kawanaka M, Morishita A, Munekage K, Kawata K, Yamamura S, Sawada K, Maeshiro T, Tobita H, Yoshida Y, Naito M, Araki A, Arakaki S, Kawaguchi T, Noritake H, Ono M, Masaki T, Yasuda S, Tomita E, Yoneda M, Kawada N, Tokushige A, Kamada Y, Takahashi H, Ueda S, Aishima S, Sumida Y, Nakajima A, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Fujii H, et al. Among authors: araki a. Clin Gastroenterol Hepatol. 2023 Feb;21(2):370-379. doi: 10.1016/j.cgh.2022.01.002. Epub 2022 Jan 17. Clin Gastroenterol Hepatol. 2023. PMID: 35051649
Palm Pustules Induced by Pemetrexed.
Nakashima K, Tsubata Y, Niihara H, Araki A, Isobe T. Nakashima K, et al. Among authors: araki a. J Thorac Oncol. 2021 Sep;16(9):1589-1591. doi: 10.1016/j.jtho.2021.06.021. Epub 2021 Jul 6. J Thorac Oncol. 2021. PMID: 34242787 Free article. No abstract available.
Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: A multicenter study in Japan.
Tsutsumi T, Kawaguchi T, Fujii H, Kamada Y, Takahashi H, Kawanaka M, Sumida Y, Iwaki M, Hayashi H, Toyoda H, Oeda S, Hyogo H, Morishita A, Munekage K, Kawata K, Sawada K, Maeshiro T, Tobita H, Yoshida Y, Naito M, Araki A, Arakaki S, Noritake H, Ono M, Masaki T, Yasuda S, Tomita E, Yoneda M, Tokushige A, Ueda S, Aishima S, Nakajima A, Okanoue T. Tsutsumi T, et al. Among authors: araki a. Aliment Pharmacol Ther. 2024 Jun;59(12):1559-1570. doi: 10.1111/apt.17995. Epub 2024 Apr 23. Aliment Pharmacol Ther. 2024. PMID: 38651312
Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease.
Nouso K, Kawanaka M, Fujii H, Kariyama K, Toyoda H, Iwaki M, Hayashi H, Oeda S, Hyogo H, Morishita A, Munekage K, Kawata K, Tsutsumi T, Sawada K, Maeshiro T, Tobita H, Yoshida Y, Naito M, Araki A, Arakaki S, Kawaguchi T, Noritake H, Ono M, Masaki T, Yasuda S, Tomita E, Yoneda M, Tokushige A, Kamada Y, Takahashi H, Ueda S, Aishima S, Sumida Y, Nakajima A, Kumada T, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG‐NAFLD). Nouso K, et al. Among authors: araki a. Hepatol Res. 2024 Oct;54(10):912-920. doi: 10.1111/hepr.14039. Epub 2024 Apr 25. Hepatol Res. 2024. PMID: 38661715
Validation of Noninvasive Markers for HCC Risk Stratification in 1389 Patients With Biopsy-proven NAFLD.
Toyoda H, Fujii H, Iwaki M, Hayashi H, Oeda S, Hyogo H, Kawanaka M, Morishita A, Munekage K, Kawata K, Yamamura S, Sawada K, Maeshiro T, Tobita H, Yoshida Y, Naito M, Araki A, Arakaki S, Kawaguchi T, Noritake H, Ono M, Masaki T, Yasuda S, Tomita E, Yoneda M, Kawada N, Tokushige A, Kamada Y, Takahashi H, Ueda S, Aishima S, Sumida Y, Nakajima A, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Toyoda H, et al. Among authors: araki a. Gastro Hep Adv. 2023 Aug 2;2(8):1093-1102. doi: 10.1016/j.gastha.2023.07.018. eCollection 2023. Gastro Hep Adv. 2023. PMID: 39131553 Free PMC article.
Endoscopic differential diagnosis between foveolar-type gastric adenoma and gastric hyperplastic polyps in Helicobacter pylori-naïve patients.
Shibagaki K, Ishimura N, Kotani S, Fukuyama C, Takahashi Y, Kishimoto K, Yazaki T, Kataoka M, Omachi T, Kinoshita Y, Hasegawa N, Oka A, Mishima Y, Mishiro T, Oshima N, Kawashima K, Nagase M, Araki A, Kadota K, Ishihara S. Shibagaki K, et al. Among authors: araki a. Gastric Cancer. 2023 Nov;26(6):1002-1011. doi: 10.1007/s10120-023-01420-2. Epub 2023 Aug 6. Gastric Cancer. 2023. PMID: 37543537
Pigmented Carcinoid in the Rectum.
Hara T, Shibagaki K, Nagase M, Takahashi Y, Kotani S, Fukuba N, Oshima N, Ishimura N, Araki A, Niino D, Ishihara S. Hara T, et al. Among authors: araki a. Pathol Int. 2025 Apr 15. doi: 10.1111/pin.70013. Online ahead of print. Pathol Int. 2025. PMID: 40230280 No abstract available.
Spectrum of gastric neoplasms in Helicobacter pylori-naïve patients.
Shibagaki K, Kushima R, Sekine S, Mishiro T, Kotani S, Miyaoka Y, Ishimura N, Araki A, Ohnuma H, Niino D, Ishihara S. Shibagaki K, et al. Among authors: araki a. Dig Endosc. 2025 Jun;37(6):611-628. doi: 10.1111/den.14980. Epub 2025 Jan 22. Dig Endosc. 2025. PMID: 39844451 Review.
Clinicopathologic differences of gastric neoplasms between Helicobacter pylori-infected and -naïve patients: a multicenter retrospective analysis.
Kotani S, Shibagaki K, Hirahara N, Hasegawa N, Tanabe R, Ebisutani Y, Nonomura S, Kishimoto K, Kodama Y, Takahashi Y, Kataoka M, Oka A, Fukuba N, Mishima Y, Oshima N, Kawashima K, Ishimura N, Araki A, Kadota K, Itawaki A, Nagasaki M, Miyaoka Y, Onuma H, Ishihara S. Kotani S, et al. Among authors: araki a. J Gastroenterol. 2024 Jan;59(1):1-10. doi: 10.1007/s00535-023-02050-2. Epub 2023 Oct 19. J Gastroenterol. 2024. PMID: 37855982
67 results